Libertas Acetabular Liners (Acetabular Liner)
Maxx Orthopedics, Inc. · Decision date Oct 29, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 2026-10-29 for K260975, a traditional 510(k) submitted by Maxx Orthopedics, Inc. of Norristown, Pennsylvania, covering Libertas Acetabular Liners (Acetabular Liner). The application was received 03/24/2026 and reviewed by the Orthopedic panel under regulation 888.3350, with JDI as the classification product code and LZO and OQI listed as subsequent product codes. Clearance under SESE is not a PMA approval.
The record identifies the device at the category level as a hip prosthesis, semi-constrained, metal/polymer, cemented, and lists no supplement type. The page states the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The summary document is linked but its contents are not included here, so materials, sizing, indications and performance data remain unknown from this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260975
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Maxx Orthopedics, Inc.
- Product code
- JDI
- Decision code
- SESE
- Decision date
- Oct 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented.
- Applicant
- Maxx Orthopedics, Inc.
- Product code
- JDI
- FDA device class
- 2
FDA decision timeline
K260975 received
Application receipt date recorded by FDA.
K260975 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Maxx Orthopedics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Norristown, PA
Sources and methodology
- Original FDA record: K260975
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records